CRL
Charles River Laboratories International, Inc. · Healthcare
EVP, Corp Strategy, Develop Joseph W Laplume sold $1.4M of Charles River Laboratories International, Inc.
Sold$1,437,205
$224.25Price
6,409Shares
−24%Stake
What CRL did after the filing
- The stock from Mon, Dec 5 close, $215.11
- +8.6%
- S&P 500, same days
- −2.3%
Measured over 30 trading days, to the Jan 19 close.
Traded Thu, Dec 1. Filed Mon, Dec 5, 11:55 AM ET, during the session. Returns use the Dec 5 close and the Jan 19 close. Not investment advice.